Product Name: 3-((Dimethylamino)propyl)triphenylphosphonium bromide CAS NO:18355-96-9
Phosphonium,[3-(dimethylamino)propyl]triphenyl-, bromide (1:1);
Chemical & Physical Properties:
Appearance : white to off white powder
Intermediate of Olopatadine hydrochloride.
Olopatadine hydrochloride (olopatadine hydrochloride) is an anti-allergic drug developed and marketed by Japan Kyowa Fermentation Company, and has been marketed in Europe, America, Japan and other countries successively. It has the dual effects of inhibiting histamine release and selectively antagonizing HI receptors, and without the central nervous system inhibition and cardiac toxic side effects common to HI receptor antagonist anti-allergic drugs. It is used orally for allergic rhinitis, skin irritation, polymorphism Treatment of sexual exudative erythema and urticaria. Its eye drops are used to treat allergic conjunctivitis. The drug can not only inhibit the release of histamine from mast cells, but also antagonize H1 receptors more selectively. It has no effect on alpha adrenergic receptors, dopamine receptors, and M1 and M2 receptors. Among them, the side effects of the central nervous system are few. , Is a new generation of anti-allergic drugs of choice.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.